FDA Brief

Warning letters Drugs

FDA warning letter to

Skull Smash LLC

High riskIssued Mar 13, 2024Posted Mar 19, 2024Center for Drug Evaluation and Research | CDER

Skull Smash LLC sold unapproved, misbranded ammonia inhalant stimulant drugs online, FDA says.

What happened

FDA reviewed Skull Smash's website on November 16, 2023, and its Facebook account on November 20, 2023, and found the ammonia inhalant products available for purchase in the United States. FDA concluded the products are unapproved new drugs and misbranded. FDA said the products are intended as stimulant drugs, contain ammonium carbonate, and are labeled for intranasal use.

What FDA found

  1. Label and website claims show the products are intended to affect body function and act as stimulant drugs.

    section 201(g)(1)(B)/(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(B)/(C); 21 CFR 201.128
  2. The ammonia inhalant products are new drugs marketed without an FDA-approved application.

    section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  3. As reflex stimulants, the ammonia products are deemed new drugs because FDA has proposed that ammonia reflex stimulants are not generally recognized as safe and effective.

    section 505G(a)(4) of the FD&C Act, 21 U.S.C. 355h(a)(4); 73 FR 34895
  4. Even as general stimulants, the products do not meet OTC Monograph M011 because they use ammonium carbonate and intranasal directions, while M011 allows only oral caffeine.

    section 505G of the FD&C Act, 21 U.S.C. 355h; OTC Monograph M011
  5. The products are misbranded because they are nonprescription drugs that do not meet section 505G and have no approved application.

    section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)

What FDA wants

FDA asks Skull Smash to respond in writing within 15 working days, saying what it has done to correct the violations and prevent recurrence; if it cannot finish, it must give reasons and a completion schedule.

Who should pay attention

  • retailers and online marketplaces selling ammonia inhalants
  • strength sports and gym suppliers promoting smelling salts
  • brands selling OTC stimulant inhalants without an approved application

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk